Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy.

Hoden, Bettina; Nagai, Yasuhiro; Schuettpelz, Laura; Zhang, Dekai

Hoden, Bettina; Nagai, Yasuhiro; Schuettpelz, Laura; Zhang, Dekai.

Afiliación

Hoden B; Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States.
Nagai Y; Cancer Research Unit, Sumitomo Pharma Co. Ltd., Osaka, Japan.
Schuettpelz L; Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States.
Zhang D; Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, United States.

Front Immunol ; 14: 1331317, 2023.

Article en En | MEDLINE | ID: mdl-38022608

Asunto(s)

Neoplasias; Receptores Toll-Like; Humanos; Neoplasias/terapia; Inmunoterapia

Palabras clave

TLR signaling; cancer; cancer immunity; immunotherapy; toll-like receptor (TLR)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Toll-Like / Neoplasias Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google